Table 1.
Pretreatment clinical characteristics categorized according to treatment administered to 156 patients with high-risk prostate cancer, adjusted for propensity scores
| Pretreatment characteristics | Radiation therapy (N = 78) | Radical prostatectomy (N = 78) | P |
|---|---|---|---|
| Age (year, median) |
73.5 |
71 |
0.0633a |
| Initial prostate-specific antigen level (ng/mL, median) |
21.42 |
20.00 |
0.3886 |
| Clinical T stage |
|
|
|
| T1c |
19 |
22 |
0.8482 |
| T2 |
23 |
19 |
|
| T3 |
36 |
37 |
|
| Biopsy Gleason score |
|
|
|
| ≤6 |
5 |
4 |
0.9384 |
| 7 |
24 |
23 |
|
| ≥8 |
49 |
51 |
|
| Follow-up period (month, median) | 37.6 | 31.5 | 0.3338 |
aP values indicate statistical significance.